Acelrx Pharmaceuticals Inc

NASDAQ:ACRX   2:56:04 PM EDT
0.63
-0.03 (-4.09%)
Earnings Announcements

AcelRx Pharmaceuticals To Acquire Lowell Therapeutics And Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 11:16 GMT
Acelrx Pharmaceuticals Inc (ACRX) - Acelrx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.07.
Agreement to Acquire Lowell in a Transaction Valued at Approximately $32.5 Million.
Agreement to Acquire Lowell in a Transaction Valued at Approximately $32.5 Million.
Acelrx - Amount of Shares of Acelrx Common Stock Valued at Approximately $6.5 Million is Expected to Be Issued to Lowell Securityholders at Closing.
Revenue is expected to be $3.4 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $1 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.